Conviction
$ Value
$186K
Shares
40,000
Price
$5
Filed
Feb 13
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ 10%+ owner (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Hannasch Brian
Title
—
CIK
0001911504
Roles
Transaction Details
Transaction Date
2026-02-11
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,171,522
Footnotes
Reflects the weighted average price of 40,000 shares of common stock of Neuraxis, Inc. purchased by the reporting person in multiple transactions on February 11, 2026 with purchase prices ranging from $4.53 to $4.85 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. | Reflects the weighted average price of 40,000 shares of common stock of Neuraxis, Inc. purchased by the reporting person in multiple transactions on February 12, 2026 with purchase prices ranging from $4.70 to $4.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Filing Info
Hannasch Brian's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-12 | NRX | ▲ | $197K |
| 2026-02-11 | NRX | ▲ | $186K |
| 2026-01-01 | AZO | A | $0 |
| 2025-12-18 | AZO | ▲ | $499K |
| 2025-07-01 | NRX | ▲ | $800K ★ |
Other Insiders at NRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Hannasch Brian | $197K | — | 2026-02-12 |
|
Carrico Brian Allen
Chief Executive Officer
|
$16K | — | 2026-04-01 |
|
Henrichs Timothy Robert
Chief Financial Officer
|
$15K | — | 2026-04-01 |
|
Carrico Thomas Joeseph
CRO, CCO, CPO
|
$1K | — | 2026-04-01 |
| Ferge Kristin A | — | — | 2026-01-22 |
| Aharon Gil | — | — | 2026-01-22 |
| Watkins Bradley Mitchell | — | — | 2026-01-22 |
| Keyser Jane Elizabeth | — | — | 2026-01-22 |
|
Miranda Adrian
CMO, SVP Science & Tech
|
— | — | 2026-01-22 |